Martyn Greenacre

Président chez CURIS, INC. Fortune : 740 $ au 31/05/2026

Profil

Martyn D.
Greenacre currently works at Curis, Inc., as Chairman from 2017, Life Mist Technologies, Inc., as Chairman from 2002, and Formula Pharmaceuticals, Inc., as Director.
Mr. Greenacre also formerly worked at Zynaxis, Inc., as President & Chief Executive Officer in 1997, Delsys Pharmaceutical Corp., as Chief Executive Officer & Director in 2001, Life Mist LLC, as Chairman from 2001 to 2016, Beijing Med-Pharm Corp., as Chairman in 2008, Smithkline Beecham Pharmaceuticals (India) Ltd., as Director & Chairman-European Operations from 1989 to 1992, BMP Sunstone Corp., as Chairman from 2004 to 2011, Cephalon, Inc., as Director from 1992 to 2011, Creative Biomolecules, Inc., as Director from 1993 to 2000, Orchestra Therapeutics, Inc., as Director in 2008, Acusphere, Inc., as Director from 2001 to 2013, NeoStem, Inc., as Director, Caladrius Biosciences, Inc., as Director in 2011, Applera Corp., as Member-Executive Committee, and Arsenal Capital Management LP, as Senior Advisor.
Mr. Greenacre received his Masters Business Admin degree from Harvard Business School and undergraduate degree from Harvard College.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
CURIS, INC. 0 %	23/03/2026	1 305 ( 0 % )	740 $	31/05/2026

Postes actifs de Martyn Greenacre

Sociétés	Poste	Début
CURIS, INC.	Président	16/05/2017
Formula Pharmaceuticals, Inc.	Directeur/Membre du Conseil	-
Life Mist Technologies, Inc.	Président	01/01/2002

Anciens postes connus de Martyn Greenacre

Sociétés	Poste	Fin
Life Mist LLC	Président	01/12/2016
Arsenal Capital Management LP	Private Equity Investor	31/03/2011
BMP Sunstone Corp.	Président	01/02/2011
Beijing Med-Pharm Corp.	Président	19/02/2008
Orchestra Therapeutics, Inc.	Directeur/Membre du Conseil	01/01/2008